AU2003231279A1 - Prevention and treatment of type 2 diabetes - Google Patents

Prevention and treatment of type 2 diabetes

Info

Publication number
AU2003231279A1
AU2003231279A1 AU2003231279A AU2003231279A AU2003231279A1 AU 2003231279 A1 AU2003231279 A1 AU 2003231279A1 AU 2003231279 A AU2003231279 A AU 2003231279A AU 2003231279 A AU2003231279 A AU 2003231279A AU 2003231279 A1 AU2003231279 A1 AU 2003231279A1
Authority
AU
Australia
Prior art keywords
diabetes
prevention
treatment
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003231279A
Other versions
AU2003231279A8 (en
Inventor
Philip David Fernsten
Subramonia Padmanabha Pillai
George Rainer Siber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
Wyeth Holdings LLC
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Holdings LLC, Wyeth LLC filed Critical Wyeth Holdings LLC
Publication of AU2003231279A1 publication Critical patent/AU2003231279A1/en
Publication of AU2003231279A8 publication Critical patent/AU2003231279A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
AU2003231279A 2002-04-30 2003-04-30 Prevention and treatment of type 2 diabetes Abandoned AU2003231279A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37661802P 2002-04-30 2002-04-30
US60/376,618 2002-04-30
PCT/US2003/013820 WO2003092619A2 (en) 2002-04-30 2003-04-30 Prevention and treatment of type 2 diabetes

Publications (2)

Publication Number Publication Date
AU2003231279A1 true AU2003231279A1 (en) 2003-11-17
AU2003231279A8 AU2003231279A8 (en) 2003-11-17

Family

ID=29401377

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003231279A Abandoned AU2003231279A1 (en) 2002-04-30 2003-04-30 Prevention and treatment of type 2 diabetes

Country Status (2)

Country Link
AU (1) AU2003231279A1 (en)
WO (1) WO2003092619A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2336147E (en) 2003-12-17 2014-07-16 Janssen Alzheimer Immunotherap A beta immunogenic peptide carrier conjugates and methods of producing same
EP2575859B1 (en) * 2010-06-03 2018-09-19 Ramot at Tel Aviv University, Ltd. Methods of treating diabetes and compositions capable of same
MX365387B (en) 2012-09-12 2019-05-31 Neurimmune Holding Ag Human islet amyloid polypeptide (hiapp) specific antibodies and uses thereof.
WO2015004633A1 (en) 2013-07-12 2015-01-15 Neotope Biosciences Limited Antibodies that recognize islet-amyloid polypeptide (iapp)
US9850302B2 (en) 2013-07-12 2017-12-26 Prothena Biosciences Limited Antibodies that recognize IAPP
WO2015083125A2 (en) * 2013-12-06 2015-06-11 Prothena Biosciences Limited Antibodies that recognize iapp
CN106536552A (en) * 2014-03-12 2017-03-22 生物控股有限公司 Novel compounds capable of antagonizing islet amyloid polypeptide (iapp) induced beta-cell damage and impaired glucose tolerance

Also Published As

Publication number Publication date
WO2003092619A3 (en) 2004-10-07
AU2003231279A8 (en) 2003-11-17
WO2003092619A2 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2003243551A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
IL218909A0 (en) Treatment of diabetes
AU2003297356A1 (en) Prevention and treatment of cardiac arrhythmias
EP1578437A4 (en) Compositions and methods for the prevention and control of insulin-induced hypoglycemia
AU2002225219A1 (en) Diagnosis and treatment of multiple sclerosis
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2003291480A1 (en) Composition for the prevention and treatment of inflammation of the ear
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
AU5840200A (en) Treatment of diabetes and related pathologies
AU2003268295A1 (en) "diagnosis and treatment of infertility"
AU2003252182A1 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
AU5908300A (en) Prevention and treatment of amyloid-associated disorders
AU2002364171A1 (en) Materials and methods for the treatment or prevention of obesity
AU2002359747A1 (en) Prevention and treatment of atherosclerosis and restenosis
AU2003238242A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2003231279A1 (en) Prevention and treatment of type 2 diabetes
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
AU2003298664A1 (en) Treatment of cognitive dysfunctions'
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2002327440A1 (en) Treatment of type i diabetes
AU2003219880A1 (en) Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003273192A1 (en) Compounds and compositions for the treatment of diabetes and diabetes-related disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase